DE60008300D1 - Oligosaccharide, Verfahren zur ihrer Herstellung und pharmazeutische Zusammensetzung die sie enthalten - Google Patents

Oligosaccharide, Verfahren zur ihrer Herstellung und pharmazeutische Zusammensetzung die sie enthalten

Info

Publication number
DE60008300D1
DE60008300D1 DE60008300T DE60008300T DE60008300D1 DE 60008300 D1 DE60008300 D1 DE 60008300D1 DE 60008300 T DE60008300 T DE 60008300T DE 60008300 T DE60008300 T DE 60008300T DE 60008300 D1 DE60008300 D1 DE 60008300D1
Authority
DE
Germany
Prior art keywords
group
residue
chem
general formula
following general
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60008300T
Other languages
English (en)
Other versions
DE60008300T2 (de
Inventor
Yuji Matsuzaki
Yousuke Yasuda
Satoshi Miyauchi
Junichi Onaya
Yusuke Hori
Akira Tawada
Hideo Mochizuki
Masami Iida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikagaku Corp
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Publication of DE60008300D1 publication Critical patent/DE60008300D1/de
Application granted granted Critical
Publication of DE60008300T2 publication Critical patent/DE60008300T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60008300T 1999-01-07 2000-01-05 Oligosaccharide, Verfahren zur ihrer Herstellung und pharmazeutische Zusammensetzung die sie enthalten Expired - Lifetime DE60008300T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP201199 1999-01-07
JP201199 1999-01-07

Publications (2)

Publication Number Publication Date
DE60008300D1 true DE60008300D1 (de) 2004-03-25
DE60008300T2 DE60008300T2 (de) 2004-07-15

Family

ID=11517442

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60008300T Expired - Lifetime DE60008300T2 (de) 1999-01-07 2000-01-05 Oligosaccharide, Verfahren zur ihrer Herstellung und pharmazeutische Zusammensetzung die sie enthalten

Country Status (6)

Country Link
US (1) US6562954B1 (de)
EP (1) EP1018515B1 (de)
AT (1) ATE259821T1 (de)
AU (1) AU6557299A (de)
CA (1) CA2293964A1 (de)
DE (1) DE60008300T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112999233B (zh) * 2019-12-19 2023-10-20 中国医学科学院药物研究所 一类来源于赤芍的单萜苷类化合物及其制法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
JPH0296588A (ja) 1988-09-29 1990-04-09 Rikagaku Kenkyusho 硫酸化オリゴ糖及びその関連物質
WO1991006303A1 (en) 1989-10-27 1991-05-16 Case Western Reserve University Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans
WO1993024506A1 (en) 1992-05-26 1993-12-09 Alberta Research Council IMMUNOSUPPRESSIVE AND TOLEROGENIC MODIFIED LEWISC AND LacNAc COMPOUNDS
MX9304638A (es) 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
WO1994006442A1 (en) 1992-09-11 1994-03-31 The Regents Of The University Of California Sulfated ligands for l-selectins and use of chlorates and or sulfatases for the treatment of inflammation
AU1255695A (en) 1993-11-19 1995-06-06 Regents Of The University Of California, The Sulfated ligands for l-selectin and methods of preventing sulfate addition
GB9422584D0 (en) 1994-02-15 1995-01-04 Medical Res Council Immunomodulation using oligosaccharides
HUT77134A (hu) 1994-12-01 1998-03-02 Seikagaku Corporation Keratán-szulfát-oligoszacharid frakciók és ilyet tartalmazó gyógyszerkészítmények és eljárás a fenti oligoszaharidok előállítására
JP4023848B2 (ja) * 1996-03-29 2007-12-19 生化学工業株式会社 硫酸化ラクトサミンオリゴ糖の製造方法
JP4179567B2 (ja) * 1996-07-23 2008-11-12 生化学工業株式会社 新規ラクトサミンオリゴ糖およびその製造方法

Also Published As

Publication number Publication date
US6562954B1 (en) 2003-05-13
DE60008300T2 (de) 2004-07-15
ATE259821T1 (de) 2004-03-15
CA2293964A1 (en) 2000-07-07
AU6557299A (en) 2000-07-13
EP1018515A1 (de) 2000-07-12
EP1018515B1 (de) 2004-02-18

Similar Documents

Publication Publication Date Title
MXPA00005376A (es) Sintesis enzimatica de gangliosidos.
KR890002211A (ko) 신규의 펜타사카라이드
MY109669A (en) N,o-sulphated heparosans, process for, preparing them and pharmaceutical compositions containing them
BR9713412A (pt) Composição cosmética adequada para aplicação tópica à pele ou cabelo e processo de tratamento cosmético
DE69522589D1 (de) Vitamin D3-Derivate und ein Verfahren zu ihrer Herstellung
IL75337A (en) Polyenoic acids omega-substituted by a 4,5-dimethoxy-2-methyl-quinone or a 4,5-dimethoxy-2-methyl-phenyl group,process for the preparation thereof and pharmaceutical compositions containing the same
KR840004761A (ko) N-글리코실화 카복스아미드 유도체의 제조방법
PT649854E (pt) Bisconjugados compreendendo dois sacaridos e um espacador
ATE178903T1 (de) Sulfamat-derivate von 1,3,5(10)-estratrien- derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
IL88396A (en) Preparation of 6-methylene derivatives of androsta-1,4- diene-3,17-diones and pharmaceutical compositions containing them
KR870007196A (ko) 화학적 제조방법
ATE8401T1 (de) Anthracyclin-glycoside, verfahren zu ihrer herstellung, zwischenprodukte und ihre herstellung und arzneimittel.
ATE238327T1 (de) Oligosaccharidderivate und verfahren zu ihrer herstellung
UA61124C2 (en) New pentasaccharides, a method for preparing thereof and pharmaceutical compositions containing them
DE60008300D1 (de) Oligosaccharide, Verfahren zur ihrer Herstellung und pharmazeutische Zusammensetzung die sie enthalten
GR3031330T3 (en) Erythromycin derivatives, their process of preparation and their application as medicaments.
ATE166060T1 (de) Neue (estradiol-derivat)-chlorambucil-konjugate, verfahren zu ihrer herstellung und pharmazeutische präparate
EP0317572A4 (de) Verfahren zur herstellung von peracetyloxazolinen.
PT75332A (fr) Procede de preparation de steroides esterifies en la position 17 et thioesterifies en la position 21 applicables comme medicament
NZ335325A (en) Erythromycin derivatives, method for preparing them and their use as medicine
DE69512910D1 (de) Alkylsulfoacetat-zusammensetzungen und verfahren zu ihrer herstellung
ATE7700T1 (de) 2-hydroxy-1,2,4-butantricarbonsaeure-oligoribosi - derivate, verfahren zu ihrer herstellung und ihre verwendung als prophylaktische mittel gegen zahnkaries.
AU6823490A (en) New substituted amino acid derivatives, process for preparing these and pharmaceutical compositions containing them
HUP9802072A2 (hu) Benzo-tiopiráno-indazol-származékok és az ezeket tartalmazó gyógyszerkészítmények
ATE119540T1 (de) Tetrasaccharidderivate, verfahren zu ihrer herstellung und verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition